Annalisa Mupo
Babraham Institute(GB)Granta Design (United Kingdom)(GB)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Protein Degradation and Inhibitors, Genomics and Chromatin Dynamics, CRISPR and Genetic Engineering, Cancer Genomics and Diagnostics
Most-Cited Works
- → A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia(2016)815 cited
- → Tbx1 haploinsufficiency is linked to behavioral disorders in mice and humans: Implications for 22q11 deletion syndrome(2006)388 cited
- → ArrayExpress update—trends in database growth and links to data analysis tools(2012)375 cited
- → Targeting Chromatin Regulators Inhibits Leukemogenic Gene Expression in NPM1 Mutant Leukemia(2016)248 cited
- → Hemopoietic-specific Sf3b1-K700E knock-in mice display the splicing defect seen in human MDS but develop anemia without ring sideroblasts(2016)124 cited
- → Synergistic targeting of FLT3 mutations in AML via combined menin-MLL and FLT3 inhibition(2020)116 cited
- → Molecular synergy underlies the co-occurrence patterns and phenotype of NPM1-mutant acute myeloid leukemia(2017)94 cited
- → Tbx1 regulates Vegfr3 and is required for lymphatic vessel development(2010)85 cited
- → A powerful molecular synergy between mutant Nucleophosmin and Flt3-ITD drives acute myeloid leukemia in mice(2013)82 cited
- → Genetic modification of primary human B cells to model high-grade lymphoma(2019)73 cited